Related Experiment Video

Updated: Sep 7, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

A step towards the ambition of precision oncology in recurrent ovarian cancer

Silvana Talisa Wijaya1, David Shao Peng Tan1,2,3

  • 1Department of Haematology-Oncology, National University Cancer Institute Singapore, Singapore.

Journal of Gynecologic Oncology
|June 17, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.4K
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.0K

Related Experiment Videos

Last Updated: Sep 7, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.4K
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.0K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

Articles linked to this work by shared authors, journal, and citation graph.

Mes/Stem-A ovarian cancer subtypes predict sensitivity to ATR inhibition.

Oncogene·2026

Spatial predictors of response to chemo-immunotherapy in microsatellite stable metastatic colorectal cancer.

Nature communications·2026

Returning to PARP Inhibition: Rechallenge with Bevacizumab in Ovarian Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Molecular profile and targeted therapies for ovarian clear cell ovarian cancer.

Therapeutic advances in medical oncology·2026

Ovarian cancer.

Nature reviews. Disease primers·2026

Prompt Engineering for Eastern Cooperative Oncology Group Status Extraction: Comparing Large Language Model Techniques.

JCO clinical cancer informatics·2026

Erratum: Mutations in homologous recombination repair genes in patients with metastatic endometrial cancer: association with clinical characteristics and prognosis.

Journal of gynecologic oncology·2026

Corrigendum: Therapeutic efficacy of laser vaporization and conization for high-grade cervical intraepithelial neoplasia.

Journal of gynecologic oncology·2026

Guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer: 2025 edition by the Japan Society of Gynecologic Oncology.

Journal of gynecologic oncology·2026

Effectiveness of first-line niraparib maintenance in Korean patients with advanced ovarian cancer: a multicenter retrospective cohort study.

Journal of gynecologic oncology·2026

Optimizing outcomes in minimally invasive radical hysterectomy: the protective role of a vaginal pipe.

Journal of gynecologic oncology·2026

Changes and clinical impact of HER3 and ERBB3 expression in primary and recurrent ovarian cancer.

Journal of gynecologic oncology·2026

Dendritic-cell-targeting adeno-associated virus as potent cancer vaccine carriers.

Frontiers in immunology·2026

Oncolytic virus VT1092M synergizes with immune checkpoint inhibitors against intraperitoneal metastases of colorectal cancer.

Frontiers in immunology·2026

Pathological mechanisms of long non-coding RNA FOXD2-AS1 promoting osteosarcoma mediated by the COI-1/OCN/Runx-2 signaling pathway.

Frontiers in medicine·2026

Efficacy and safety of bevacizumab plus XELOX in patients with unresectable locally advanced or metastatic neuroendocrine tumors.

Frontiers in endocrinology·2026

Mitochondria-targeted ROS-scavenging nanoreactor with dual-drug-loaded carbon dots for osteoarthritis therapy.

Journal of materials chemistry. B·2026

Pharmacological inhibition of MCL-1 disrupts mitochondrial cristae and depletes the human neural progenitor cell pool.

Journal of cell science·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us